Cite
HARVARD Citation
Garcia-Manero, G. et al. (n.d.). CC-486 (Oral Azacitidine) Induces Responses in Patients with Hematological Malignancies Who had Failed Prior Treatment with Injectable Hypomethylating Agents (HMAS). Leukemia research. pp. S14-S16. [Online].